Share on StockTwits
 

Mednax (NYSE:MD) posted its quarterly earnings results on Thursday. The company reported $0.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.75 by $0.55, American Banking and Market News reports.

A number of research firms have recently commented on MD. Analysts at KeyCorp initiated coverage on shares of Mednax in a research note to investors on Tuesday, December 17th. They set a “hold” rating on the stock. On the ratings front, analysts at Jefferies Group raised their EPS on shares of Mednax in a research note to investors on Monday, November 11th. They now have a “buy” rating and a $125.00 price target on the stock. They previously had a $108.00 price target on the stock. Finally, analysts at Dougherty & Co raised their price target on shares of Mednax from $110.00 to $125.00 in a research note to investors on Monday, November 4th. They now have a “buy” rating on the stock. Eight research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Mednax has a consensus rating of “Hold” and an average target price of $106.57.

Shares of Mednax (NYSE:MD) opened at 52.97 on Thursday. Mednax has a 52 week low of $41.825 and a 52 week high of $56.445. The stock’s 50-day moving average is $53.69 and its 200-day moving average is $51.92. The company has a market cap of $5.271 billion and a price-to-earnings ratio of 20.24.

MEDNAX, Inc (NYSE:MD) is a provider of physician services, including newborn, maternal-fetal, pediatric subspecialties and anesthesia care.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.